What is the ROE (Return on Equity) of Zomedica this year?
The ROE of Zomedica this year is -0.14 undefined.
Zomedica ROE 2024
Zomedica ROE
-0.14
Ticker
ZOM
ISIN
CA98980M1095
WKN
A2QEF3
In 2024, Zomedica's return on equity (ROE) was -0.14, a 126.08% increase from the -0.06 ROE in the previous year.
Zomedica Aktienanalyse
What does Zomedica do?
Zomedica Corp is an emerging company specializing in the development and marketing of innovative diagnostics and treatment options for pets. The company was founded in 2015 and is headquartered in Ann Arbor, Michigan. Zomedica's business model is primarily focused on providing better diagnostics and therapy for pets to veterinarians and pet owners. The company develops and markets veterinary diagnostics and precise treatment solutions for various diseases in pets. Zomedica is divided into different divisions specializing in different areas of veterinary diagnostics and therapy. One of these divisions is "Point-of-Care" diagnostics, which allows veterinarians to perform quick and accurate diagnoses directly in their practice. Zomedica offers innovative devices and tests for the rapid diagnosis of diseases such as prostatitis or hypothyroidism. Another important division is "Companion Diagnostic" diagnostics, which is specifically focused on the diagnosis of cancer in pets. Zomedica has developed innovative tests that enable quick and precise diagnoses, allowing for targeted therapy initiation. In addition to diagnostics, Zomedica also offers innovative therapy solutions for pets. The company focuses on the development of antibiotics for animals, as well as precise treatment solutions for diseases such as diabetes or chronic kidney disease. One of Zomedica's best-known products is TRUFORMA, an innovative diagnostic device for veterinarians that enables quick and precise diagnosis of various diseases. The company has also developed a range of tests for the diagnosis of thyroid disease, prostatitis, and diabetes. In recent years, Zomedica has become one of the leading companies in veterinary diagnostics and therapy and has already convinced numerous veterinarians and pet owners of its innovative products and solutions. The company relies on close collaboration with veterinarians to continuously improve its products and tailor them to the needs of the market. Overall, Zomedica is an innovative company specializing in products and solutions for the needs of veterinarians and pet owners. With its innovative diagnostics and treatment solutions, the company is setting new standards in veterinary medicine and contributing to the improvement of pet health worldwide. Zomedica ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding Zomedica's Return on Equity (ROE)
Zomedica's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing Zomedica's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
Zomedica's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in Zomedica’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about Zomedica stock
How has the Return on Equity (ROE) of Zomedica developed compared to the previous year?
The ROE of Zomedica has increased by 126.08% increased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of Zomedica?
A high ROE indicates that Zomedica generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of Zomedica?
A low ROE can indicate that Zomedica is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of Zomedica affect the company?
A change in ROE (Return on Equity) of Zomedica can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of Zomedica?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of Zomedica?
Some factors that can influence Zomedica's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does Zomedica pay?
Over the past 12 months, Zomedica paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Zomedica is expected to pay a dividend of 0 USD.
What is the dividend yield of Zomedica?
The current dividend yield of Zomedica is .
When does Zomedica pay dividends?
Zomedica pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Zomedica?
Zomedica paid dividends every year for the past 0 years.
What is the dividend of Zomedica?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Zomedica located?
Zomedica is assigned to the 'Health' sector.
Wann musste ich die Aktien von Zomedica kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Zomedica from 9/18/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/18/2024.
When did Zomedica pay the last dividend?
The last dividend was paid out on 9/18/2024.
What was the dividend of Zomedica in the year 2023?
In the year 2023, Zomedica distributed 0 USD as dividends.
In which currency does Zomedica pay out the dividend?
The dividends of Zomedica are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Zomedica
Our stock analysis for Zomedica Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Zomedica Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
